Pharmafile Logo
Pharmafocus logo
Advanced Search
shutterstock_187433765_16

European Commission approves treatment of unresectable uveal melanoma

April 5, 2022
Manufacturing and Production

Immunocore Holdings has announced that the European Commission has approved KIMMTRAK® (tebentafusp) for the treatment of HLA-A*02:01-positive adult patients with …

News

Technology enabling thermally-controlled DNA synthesis

April 5, 2022
Manufacturing and Production

Evonetix has been granted a patent in Europe for thermal control technology for DNA synthesis, as well as the design …

News

NHS struggling to make progress on early cancer diagnosis

April 5, 2022
Manufacturing and Production

MPs have warned that the NHS in England is struggling to make progress on its flagship target to diagnose three-quarters …

News

FDA approves generic version of brain imaging agent in US

April 5, 2022
Manufacturing and Production

The FDA has approved the generic version of DaTscan (Ioflupane I 123), manufactured and commercialised by Curium. This is a …

News
leipzig_skyline

FlyPharma Conference Europe: New dates and location announced

April 4, 2022
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

FlyPharma Conferences are pleased to announce that FlyPharma Europe is returning as a live, in-person event in 2022.

News

AI test could predict effective cancer drug combinations in less than two days

April 4, 2022
Sales and Marketing

Scientists have created a prototype test that can predict which drug combinations are likely to work for cancer patients in …

News

FDA accepts Dupixent for Priority Review in patients 12+ with eosinophilic esophagitis

April 4, 2022
Sales and Marketing

The FDA has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent (dupilumab), in patients aged 12 …

News

New centre targets ‘undruggable’ cancers

April 4, 2022
Sales and Marketing

The new Centre for Protein Degradation has been launched, made possible by a £9 million donation to The Institute of …

News

COVID-19 vaccines now available for five to 11-year olds in England

April 4, 2022
Sales and Marketing

Parents and carers of five to 11-year olds in England can now book a low-dose COVID-19 vaccine for their children. …

News

FDA places two clinical holds on CytoDyn HIV and COVID-19 programmes

April 1, 2022
Medical Communications

The FDA has placed a partial hold on CytoDyn’s HIV program, and a full clinical hold on its COVID-19 program …

News

Biomodex launches clear cartridges for neurovascular training

April 1, 2022
Medical Communications

Biomodex has announced the launch of clear cartridges for use with Biomodex’s EVIAS and EVIAS Plus stations.The cartridges are 3D …

News

Isturisa effective in treating rare Cushing’s disease

April 1, 2022
Medical Communications

Recordati Rare Diseases has announced the publication of positive results from the Phase III LNC 4 study, confirming the efficacy …

News

UK app launched for people living with glaucoma

April 1, 2022
Medical Communications

Santen UK has launched a new app for people living with glaucoma, in partnership with Glaucoma UK, the leading charity …

News

New research finds patient satisfaction with GP services has dropped since pre-pandemic

March 31, 2022

GP leaders have said that it is ‘unsurprising’ that more people are dissatisfied with the NHS than are satisfied, and …

News

FDA approval of Cabenuva for adolescents living with HIV

March 31, 2022
Business Services

ViiV Healthcare, the global specialist HIV company, today announced the FDA approval of Cabenuva (cabotegravir, rilpivirine), for the treatment of …

News

Carteyva receives IND approval for clinical trial in second-line large b-cell lymphoma

March 31, 2022
Business Services

An investigational new drug (IND) clearance from the National Medical Products Administration (NMPA) of China, for a pivotal clinical trial …

News

250,000 with diabetes to benefit from real time information after updated NICE recommendations

March 31, 2022
Business Services

Over 250,000 people living with type 1 diabetes are set to be offered new technology to help them manage their …

News

Kesimpta-treated adults with multiple sclerosis not at risk of severe COVID-19

March 30, 2022
Business Services

The peer-reviewed journal Neurology and Therapy has published new data on COVID-19 infections in people living with remitting multiple sclerosis …

News

Carthera’s SonoCloud demonstrates potential in Alzheimer’s patients

March 30, 2022
Business Services

Carthera has announced the publication of results in the Alzheimer’s Research & Therapy Journal, from an investigator-sponsored trial evaluating the …

News

Iktos announces a collaboration with Ono for new drug design

March 30, 2022
Research and Development

Iktos, a company specialised in AI for new drug design today announced a collaboration agreement with Ono Pharmaceuticals, on innovative …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026